Skip to content

Sport in patients with neuromuscular diseases

Sport in patients with neuromuscular diseases - Sport NMD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033171
Enrollment
490
Registered
2023-12-01
Start date
2022-02-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary Myopathies idiopathic inflammatory myopathies Hereditary neuropathies Inflammatory Neuropathies Neuromuscular transmission disorders

Interventions

Group 1: Participants with different neuromuscular diseases are surveyed about sports and physical activities, data is correlated with information from patient recors. Subgroup from study population r

Sponsors

Universitätsmedizin Göttingen, Klinik für Neurologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Secure diagnosis of myopathy, neuropathy, neuromuscular transmission disorder - Able to give consent or legal guardian able to give consent

Exclusion criteria

Exclusion criteria: - patient with unclear neuromuscular disease without certain diagnosis - Unable to give consent (patient or legal guardian)

Design outcomes

Primary

MeasureTime frame
Assessment of nature and frequency of physical activity in patients with neuromuscular diseases and evaluation of the subjective effect.

Secondary

MeasureTime frame
Reconstruction of subjective perception of impact of sport and physical activity. Percentage of patients experiencing pain after movement and most common diagnosis with this experience. Detection of negative assumptions about physical activity (e.g. results in disease progression) and reasons for these beliefs.

Countries

Germany

Contacts

Public ContactJana Zschüntzsch

Universitätsmedizin Göttingen

j.zschuentzsch@med.uni-goettingen.de+49 551 3965683

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026